이벤트: Meet with Novotech at JPM to discuss accelerated FIH pathways, smarter regional strategies, and global execution designed for biotech momentum.
What we offer biotechs:
Move faster
- Start first-in-human (FIH) in Australia without an IND, using established regulatory pathways and experienced local teams.
- Activate sites quickly in high-performing regions so you can reach decision-making data sooner and avoid slow-start bottlenecks.
Spend smarter
- Tap capital-efficient regions across APAC and China, where startup, monitoring, and enrollment costs can be significantly lower than in traditional markets.
- Structure studies to balance cost, speed, and quality, ensuring every dollar is focused on reaching your next milestone—not on unnecessary rerouting.
Scale globally
- Integrate North America, Europe, and APAC under one coordinated operating model, with consistent governance and communication.
- Benefit from transparent delivery and predictable timelines to support board, partner, and investor discussions.
If your science is ready to move, we’re ready to help you move faster.
